Evidence map›Paper›PMID 42573100›Full record

ArticleThe Journal of international medical research2026

Threshold-based association between controlled attenuation parameter-defined hepatic steatosis and hepatectomy-associated ischemia-reperfusion injury: A retrospective cohort study.

Yiyun Gao, Ye Zhang, Jian Xu, Jinguo Xia, Wenyu Shao, Haoming Zhou

Abstract read
In one paragraph

Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiyun GaoHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Chinese Academy of Medical Sciences, China.ORCID 0009-0007-6885-9355
Ye ZhangHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Chinese Academy of Medical Sciences, China.
Jian XuHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Chinese Academy of Medical Sciences, China.
Jinguo XiaHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Chinese Academy of Medical Sciences, China.
Wenyu ShaoHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Chinese Academy of Medical Sciences, China.
Haoming ZhouHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Chinese Academy of Medical Sciences, China.ORCID 0000-0003-2778-221X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveFatty liver is known to aggravate hepatic ischemia-reperfusion injury; however, the relationship between the preoperative controlled attenuation parameter measured by transient elastography and ischemia-reperfusion injury after hepatectomy has not been fully clarified. This study aimedt to explore the association between controlled attenuation parameter-defined hepatic steatosis and hepatic ischemia-reperfusion injury after hepatectomy.MethodsIn this single-center retrospective study, 1461 patients who underwent hepatectomy between 2022 and 2024 were included and stratified into four groups according to controlled attenuation parameter-based steatosis grades. The primary endpoints were peak alanine aminotransferase and aspartate aminotransferase levels within 3 days after surgery. Secondary endpoints comprised additional postoperative laboratory indices and short-term clinical outcomes, including complications and mortality. Data were analyzed using multivariable linear regression, restricted cubic spline modeling to explore nonlinear associations, and propensity score matching to compare patients with grade 3 and grade 0 steatosis.ResultsCompared with the nonsteatotic group, only patients with severe fatty liver (controlled attenuation parameter > 292 dB/m) exhibited significantly higher postoperative alanine aminotransferase and aspartate aminotransferase levels. However, restricted cubic spline analysis did not demonstrate a significant positive dose-response relationship between controlled attenuation parameter and liver enzyme levels. In multivariable models, severe fatty liver was independently associated with elevated peak alanine aminotransferase, whereas no consistent association was observed for aspartate aminotransferase. After propensity score matching, severe steatosis remained associated with higher alanine aminotransferase, without significant differences in aspartate aminotransferase or major short-term clinical outcomes.ConclusionsPreoperative controlled attenuation parameter assessment is most valuable for identifying patients with severe hepatic steatosis, who appear more susceptible to aggravated ischemia-reperfusion injury after hepatectomy, rather than for predicting ischemia-reperfusion injury severity across the full controlled attenuation parameter spectrum.

Indexed as

Fatty LiverHepatectomyPostoperative ComplicationsReperfusion InjuryAgedAlanine TransaminaseAspartate AminotransferasesElasticity Imaging TechniquesFemaleHumansLiverMaleMiddle AgedRetrospective StudiesAlanine TransaminaseAspartate AminotransferasesControlled attenuation parameterhepatic ischemia–reperfusion injuryhepatic steatosispartial hepatectomyportal triad clamping

Identifiers

PMID42573100
PMCPMC13474231

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.